retatrutide parkinson's disease trial clinical retatrutide parkinson's disease clinical trial Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2023 Update-150cent Retatrutide Delivers Significant Hemoglobin A1C

DPP-4 (CD26) inhibitor alogliptin inhibits atherosclerosis in diabetic apolipoprotein E-deficient mice

Can GLP-1 medications help with alcohol cravings

Dietmicrobiome interactions and systemic health The Lancet Diabetes & Endocrinology (2024)

Though the observational data does appear rife with reverse causation, a study published interventional data in mice and in vitro on 2/27/23 that suggests erythritol may indeed be harmful, and so I urge everyone to stop consuming it until we know more

Choose MyFitnessPal when food-database breadth outweighs medication-history depth

Mounjaro & Zepbound: 3 days to administer a late dose